Herpes simplex virus types 1 and 2 in Switzerland;Herpes-simplex-virus typ 1 und 2 in der Schweiz

Schweizerische Medizinische Wochenschrift

Volumn 130, Issue 5, 2000, Pages 143-150

  Laubereau, B ^a   Zwahlen, M ^b   Neuenschwander, B ^b   Heininger, U ^a   Schaad, U B ^a   Desgrandchamps, D ^a,c  

^a UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

^b Abt Epidemiol I   (Switzerland)

^c NONE   (Switzerland)

Author keywords

Asymptomatic infections; Herpes simplex virus type 1 and 2; Seroprevalence; Switzerland

Indexed keywords

VIRUS ANTIBODY;

ADULT; ARTICLE; FEMALE; GENITAL HERPES; HERPES SIMPLEX VIRUS 1; HERPES SIMPLEX VIRUS 2; HERPES VIRUS INFECTION; HUMAN; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; SEROCONVERSION; SEROPREVALENCE; SWITZERLAND;

ADULT; ANTIBODIES, VIRAL; EUROPE; FEMALE; HERPES GENITALIS; HERPES SIMPLEX; HERPESVIRUS 1, HUMAN; HERPESVIRUS 2, HUMAN; HUMANS; MALE; MIDDLE AGED; PREVALENCE; SEX FACTORS; SWITZERLAND;

EID: 0034606985     PISSN: 00367672     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Fleming DT, McQuillan GM, Johnson RE, Nahiamas AJ, Aral SO, Lee FK, et al. Herpes simplex virus type 2 in the United States, 1976 to 1994. N Engl J Med 1997;337: 1105-11.
2. Fosgren M, Skoog E, Jeansson S, Olofsson S, Giessccke J. Prevalence of antibodies to herpes simplex virus in pregnant women in Stockholm in 1969, 1983 and 1989: implications for STD epidemiology. Int J Std Aids 1994;5:113-6.
3. Schomogyi M, Wald A, Corey L. Herpes simplex virus-2 infection. An emerging disease? Infect Dis Clin Am 1998;12: 47-61.
4. Cowan FM, Johnson AM, Ashley R, Mindel A. Relationship between antibodies to herpes simplex virus (HSV) and symptoms of HSV infection. J Infect Dis 1996;174:470-5.
5. Mertz GJ. Epidemiology of genital herpes infections. Infect Dis Clin North Am 1993;7:825-39.
6. Fonnest G, de la Fuente I, Weber T. Neonatal herpes in Denmark from 1977-1991. Acta Obstet Gynecol Scand 1997; 76:355-8.
7. Sullivan- Bollyai J, Hull HF, Wilson C, Corey L. Neonatal herpes simplex virus infection in King County, Washington: Increasing incidence and epidemiologic correlates. JAMA 1983;250:3059-62.
8. Telzak EE, Chiasson C, Bevier PJ, Stoneburner RL, Castro KG, Jaffe HW. HIV-1 seroconversion in patients with and without genital ulcer disease. Ann Intern Med 1993;119: 1181-6.
9. Boulos R, Ruff AJ, Nahmias A, Holt E, Harrison L, Magder L, et al. Herpes simplex virus type-2 infection, syphilis, and hepatitis B virus infection in Haitian women with human immunodeficiency virus typel and human T lymphotrophic virus type 1 infections. J Infect Dis 1992;166:418.
10. Greenblatt RM, Lukehart SA, Plummer FA, Quinn TC, Critchlow CW, Ashley RL, et al. Genital ulceration as a risk factor for human immunodeficiency virus infection. AIDS 1988;2:47-50.
11. Holmberg SD, Stewart JA, Gerber AR, Byers RH, Lee FK, O'Malley PM, et al. Prior herpes simplex virus type 2 infection as a risk factor for HIV infection. JAMA 1988;259: 1048-50.
12. Hook EW, Cannon RO, Nahmias AJ, Lee FF, Campbell CH Jr, Glasser D, et al. Herpes simplex virus infection as a risk factor for human immunodeficiency virus infection in heterosexuals. J Infect Dis 1992;165:251-5.
13. Stamm WE, Handsfield HH, Romppalo AM, Ashley RL, Roberts PL, Corey L. The association between genital ulcer disease and acquisition of HIV in homosexual men. JAMA 1988;260:1429-33.
14. Ross JDC, Smith IW, Elton RA. The epidemiology of herpes simplex types 1 and 2 infection of the genital tract in Edinburgh 1978-1991. Genitourin Med 1993;69:381-3.
15. Lafferty WE, Coombs RW, Benedetti J, Critchlow C, Corey L. Recurrences after oral and genital herpes simplex virus infection. Influence of site of infection and viral type. N Engl J Med 1987;316:1444-9.
16. Wald A, Zeh J, Selke S, Ashley RL, Corey L. Virologic characteristics of subclinical and symptomatic genital herpes infections. N Engl J Med 1995;333:770-5.
17. Wald A, Corey L, Cone R, Hobson A, Gray D, Zeh J. Frequent genital herpes simplex 2 shedding in immunocompetent women. Effect of acyclovir treatment. J Clin Invest 1997; 99:1092-7.
18. Pasquini P, Mele A, Franco E, Ippolito G, Svennerholm B. Prevalence of herpes simplex virus 2 antibodies in selected population groups in Italy. Eur J Microbiol Infect Dis 1988;7: 54-6.
19. Kjaer SK, de Villiers EM, Haugaard BJ, Christensen RB, Teisen C, Moeller KA, et al. Human papillomavirus, herpes simplex virus and cervical cancer incidence in Greenland and Denmark. A population- based cross-sectional study. Int J Cancer 1988;41:518-24.
20. Christensson B, Bottiger M, Svensson A, Jeansson S. A 15-year surveillance study of antibodies to herpes simplex virus type 1 and 2 in a cohort of young girls. J Infect 1992;25: 147-54.
21. Ades AE, Peckham CS, Dale GE, Best JM, Jeansson S. Prevalence of antibodies to herpes simplex virus types 1 and 2 in pregnant women, and estimated rates of infection. J Epid Comm Health 1989;43:53-60.
22. Löwenhagen GB, Jansen E, Nordenfelt E, Lycke E. Epidemiology of genital herpes infections in Sweden. Acta Derm Venereol 1990;70:330-4.
23. WHO regional office for Europe, Copenhagen. Epidemiology of herpes simplex virus infections and surveillance of other STDs in Europe. Report on a Workshop. Copenhagen, 19-20 June 1995
24. Cowan FM, Johnson AM, Ashley R, Corey L, Mindel A. Antibody to herpes simplex virus type 2 as serologic marker of sexual lifestyle in populations. Br Med J 1994;309:1325-9.
25. McGeoch DJ, Moss HWM, McNab D, Frame MC. DNA sequence and genetic content of the HindIII region in the short unique component of the herpes simplex virus type 2 genome: Identification of the gene encoding glycoprotein G, and evolutionary comparisons. J Gen Virol 1987;68:19-38.
26. Karpinski KF, Hayward S, Tryphonas H. Statistical considerations in the quantification of serum immunoglobulin levels using the enzyme-linked immunosorbent assay (ELISA). J Immunol Methods 1987;103:189-94.
27. Ades AE, Nokes DJ. Modeling age- and time-specific incidence from seroprevalence: toxomplasmosis. AJE 1993;137: 1022-34.
28. Tanner MA. Tools for statistical inference: methods for the exploration of posterior distributions and likelihood functions. 3rd ed. New York: Springer; 1996.
29. Gelman A, Carlin JB, Stern HS, Rubin DB. Bayesian Data Anaylsis. New York: Chapman & Hall; 1995.
30. Gibson JJ, Hornung CA, Alexander GR, Lee FK, Potts WA, Nahmias AJ. A cross-sectional study of herpes simplex virus types 1 and 2 in college students: occurrence and determinants of infection. J Infect Dis 1990;162:306-12.
31. Johnson RE, Nahmias AJ, Magder LS, Lee FK, Brooks CA, Snowden CB. A Seroepidemiologic Survey of the prevalence of herpes simplex virus type 2 infection in the United States. N Engl J Med 1989;321:7-12.
32. Hashido M, Lee FK, Nahmias AJ, Tsugami H, Isomura S, Nagata Y, et al. An epidemiologic study of herpes simplex virus type 1 and 2 infection in Japan based on type-specific serological assays. Epidemiol Infect 1998;120:179-86.
33. Breinig MK, Kingsley LA, Armstrong JA, Freeman DJ, Ho M. Epidemiology of genital herpes in Pittsburgh: serologic, sexual, and and racial correlates of apparent and inapparent herpes simplex infections. J Infect Dis 1990;162:299-305.
34. Mertz GJ, Benedetti J, Ashley R, Selke SA, Corey L. Risk factors for the sexual transmission of genital herpes. Ann Intern Med 1992;116:197-202.
35. Whitley RJ, Corey L, Arvin A, Lakeman FD, Sumaya CV, Wright PF, et al. Changing presentation of herpes simplex virus infection in neonates. J Infect Dis 1988;158:109-16.
36. Langenberg A, Benedetti J, Jenkins J, Ashley R, Winter C, Corey L. Development of clinically recognizable genital lesions among women previously identified as having "asymptomatic" herpes simplex virus type 2. Ann Intern Med 1989; 110:882-7.
37. Wald A, Kim M, Catlett L, Selke S, Ashley R, Corey L. Genital HSV-2 shedding in women with HSV-2 antibodies but without a history of genital herpes [Abstract H80]. In: Programs and Abstracts of the 36th Interscience Conference on Antimicrobial Agents and Chemotherapy, New Orleans, 1996; p. 177.
38. Frenkel LM, Garratty EM, Shen JP, Wheeler N, Clark O, Bryson YJ. Clinical reactivation of herpes simplex virus type 2 infections in seropositive pregnant women with no history of genital herpes. Ann Intern Med 1993;118:414-8.
39. Corey L. First-episode, recurrent and asymptomatic herpes simplex infections. J Am Acad Dermatol 1988;18:169-72.
40. Rattray MC, Corey L, Reeves WC, Vontver LA, Holmes KK. Recurrent genital herpes among women: symptomatic vs. asymptomatic viral shedding. Br J Vener Dis 1978;54:262-5.
41. Mertz GJ, Schmidt O, Jourden JL, Guinan ME, Remington ML, Fahnlander A, et al. Frequency of acquisition of first-episode genital infection with herpes simplex virus from symptomatic and asymptomatic source contacts. Sex Transm Dis 1985;12:33-9.
42. Bryson Y, Dillon M, Bernstein DI, Radolf J, Zakowski P, Garraty E. Risk of acquisition of genital herpes simplex virus type 2 in sex partners of persons with genital herpes. A prospective couple study. J Infect Dis 1993;167:942-6.